These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 69003)

  • 41. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adherent Ia+ murine tumor lines with characteristics of dendritic cells. I. Morphology, surface phenotype, and induction of syngeneic mixed lymphocyte reactions.
    Cohen DA; Kaplan AM
    J Exp Med; 1981 Dec; 154(6):1881-98. PubMed ID: 6459398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice.
    Risser R; Stockert E; Old LJ
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3918-22. PubMed ID: 211509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia.
    Dean JH; McCoy JL; Law LW; Maurer BA; Appella E
    Int J Cancer; 1975 Nov; 16(5):701-12. PubMed ID: 1184239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic T cell response against lymphoblasts infected with Moloney (Abelson) murine leukemia virus. Methodological aspects and H-2 requirements.
    Stukart MJ; Vos A; Melitef CJ
    Eur J Immunol; 1981 Mar; 11(3):251-7. PubMed ID: 6972310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours.
    Gomard E; Duprez V; Henin Y; Levy JP
    J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of gp70-specific suppressor T-cells in mice inoculated with virus-producing tumor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1982 Oct; 69(4):953-9. PubMed ID: 6214655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.
    Chesebro B; Wehrly K
    J Exp Med; 1976 Jan; 143(1):85-99. PubMed ID: 1081583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction.
    Nussenzweig MC; Steinman RM
    J Exp Med; 1980 May; 151(5):1196-212. PubMed ID: 6445399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
    Wagner H; Röllinghoff M
    J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of T cell-mediated immunity by tumor cells: immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors.
    Ting CC; Rodrigues D; Ting RC; Wivel N; Collins MJ
    Int J Cancer; 1979 Nov; 24(5):644-55. PubMed ID: 160896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virus.
    Oliff A; Agranovsky O; McKinney MD; Murty VV; Bauchwitz R
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3306-10. PubMed ID: 2987918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.